Publications
Zeyn Y, Hobernik D, Wilk U, Pöhmerer J, Hieber C, Medina-Montano C, Röhrig N, Strähle CF, Thoma-Kress AK, Wagner E, Bros M*, Berger S* (2023) Transcriptional Targeting of Dendritic Cells Using an Optimized Human Fascin1 Gene Promoter. Int. J. Mol. Sci. 24(23):16938. *corresponding authors. doi.org/10.3390/ijms242316938
Kemeter L, Birzer A, Heym S, Thoma-Kress AK (2023) Milk transmission of mammalian retroviruses. Mircoorganisms. 11(7):1777. doi: 10.3390/microorganisms11071777.
Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M, Lansing F, Schneider PM, Sonntag J, Hauber J, Thoma-Kress AK, Buchholz F (2023) Precise excision of HTLV-1 provirus with a designer-recombinase. Mol. Therapy S1525-0016(23)00135-1. doi:10.1016/j.ymthe.2023.03.014.
Schnell AP, Kohrt S, Aristodemou A, Taylor GP, Bangham CRM, Thoma-Kress AK (2022) HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients' T-cells. Front. Immunol. 13:978800. doi: 10.3389/fimmu.2022.978800
Heym S, Mohr CF, Engelbrecht HC, Fleckenstein B, Thoma-Kress AK (2022) Alternative NF-κB Signaling Discriminates Induction of the Tumor Marker Fascin by the Viral Oncoproteins Tax-1 and Tax-2 of Human T-Cell Leukemia Viruses. Cancers. 14(3):537. doi: 10.3390/cancers14030537.
Millen S, Thoma-Kress AK (2022) Milk Transmission of HTLV-1 and the need for innovative prevention strategies. Front Med. 9:867147. doi: 10.3389/fmed.2022.867147.
Kohrt S, Strobel S, Mann MC, Sticht H, Fleckenstein B, Thoma-Kress AK (2021) Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation. Int. J. Mol. Sci. 2(24), 13597; doi: 10.3390/ijms222413597.
Schnell AP, Kohrt S, Thoma-Kress AK (2021) Latency Reversing Agents: Kick and Kill of HTLV-1? Int. J. Mol. Sci. 22(11):5545. doi: 10.3390/ijms22115545.
Thoma-Kress AK, Desrosiers RC, Gack MU, Jung JU, Überla K, Kirchhoff F (2021) Biographical Feature: Bernhard Fleckenstein. J Virol. 95(17):e0089621. doi: 10.1128/JVI.00896-21.
Donhauser N, Socher E, Millen S, Heym S, Sticht H, Thoma-Kress AK (2020) Transfer of HTLV-1 p8 and Gag to target T-cells depends on VASP, a novel interaction partner of p8. PLoS Pathogens, 16(9):e1008879. doi: 10.1371/journal.ppat.1008879.
Millen S, Meretuk L, Göttlicher T, Schmitt S, Fleckenstein B, Thoma-Kress AK (2020) A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells. Retrovirology. 17(1):30. doi: 10.1186/s12977-020-00538-w.
Thoma-Kress AK, Überla K (2020) Von der antiviralen Chemotherapie bis zur Immunintervention. Trillium Immunologie; 4(2).
Millen S, Gross C, Donhauser N, Mann MC, Péloponèse JM Jr, Thoma-Kress AK (2019) Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission. Front Microbiol. 10:2439. doi: 10.3389/fmicb.2019.02439.
Dohauser N, Heym S, Thoma-Kress AK (2018) Quantitating the Transfer of the HTLV-1 p8 Protein between T-cells by Flow Cytometry. Front Microbiol. 9:400. doi: 10.3389/fmicb.2018.00400.
Manicone M, Rende F, Cavallari I, Thoma-Kress AK, Ciminale V (2017) Expression of HTLV-1 Genes in T-cells using RNA Electroporation. In: Human T-Lymphotropic Viruses – Methods and Protocols. Editor: Claudio Casoli. Methods Mol Biol. 1582:155-170. DOI:10.1007/978-1-4939-6872-5_12.
Gross C, Thoma-Kress AK (2017) Reporter Systems To Study HTLV-1 Transmission. In: Human T-Lymphotropic Viruses – Methods and Protocols. Editor: Claudio Casoli. Methods Mol Biol. 1582:33-46. DOI: 10.1007/978-1-4939-6872-5_3.
Gross C, Wiesmann V, Millen S, Kalmer M, Wittenberg T, Gettemans J, Thoma-Kress AK (2016) The Tax-inducible Actin-bundling Protein Fascin is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1). PLoS Pathogens, 12(10):e1005916. DOI: 10.1371/journal.ppat.1005916
Gross C, Thoma-Kress AK (2016) Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission. Viruses. 8(3),74. DOI: 10.3390/v8030074
Wiesmann V, Groß C, Franz D, Thoma-Kreß AK, Wittenberg T. (2016) Combining Active Contours and Active Shapes for Segmentation of Fluorescently Stained Cells. Application to Virology. In: T. Tolxdorff et al. (Hrsg.). Informatik aktuell. Bildverarbeitung für die Medizin 2016. Springer-Verlag Berlin Heidelberg. Pp 122-127. DOI 10.1007/978-3-662-49465-3_23
Mohr CF, Gross C, Bros M, Reske-Kunz AB, Biesinger B, Thoma-Kress AK (2015) Regulation of the tumor marker Fascin by the viral oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) depends on promoter activation and on a promoter-independent mechanism. Virology. 485:481-491. doi: 10.1016/j.virol.2015.08.025.
Thoma-Kress AK (2015) Humane T-Zell-Leukämieviren (HTLV-1, HTLV-2). In: Handbuch der Infektionskrankheiten-59. Erg. Lfg., Hrsg. Hofmann, F., Ecomed Verlag.
Mohr CF, Kalmer M, Gross C, Mann MC, Sterz KR, Kieser A, Fleckenstein B, Kress AK (2014)
The tumor marker Fascin is induced by the EBV-encoded oncoprotein LMP1 via NF-kappaB signals in lymphocytes and contributes to their invasive migration. Cell Communication and Signaling. 12(1):46. doi: 10.1186/s12964-014-0046-x.Mann MC, Strobel S, Fleckenstein B, Kress AK (2014) The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein Tax. Virology. 464-465:98-110. doi: 10.1016/j.virol.2014.06.028.
Kress AK, Fleckenstein B (2014) Adulte T-Zell-Leukämie durch das Humane T- lymphotrope Virus Typ 1 (HTLV-1). Onkologie heute, 05/2014, 12. Jahrgang, Juni 2014.
Ooms M, Krikoni A, Kress AK, Simon V, Münk C (2012) APOBEC3A, APOBEC3B and APOBEC3H haplotype 2 restrict Human T-lymphotropic virus type I (HTLV-1). J Virol. 86:6097-108. doi: 10.1128/JVI.06570-11.
Kress AK (2012) Humanes T-Zell-Leukämie Virus Typ 1 (HTLV-1) - Infektion, Pathogenese und Therapie. Retrovirus Bulletin; 4.
Kress AK*, Kalmer M, Rowan A, Grassmann R, Fleckenstein B (2011) The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals. Blood. 117:3609-3612. *corresponding author. doi: 10.1182/blood-2010-09-305805.
Kress AK*, Grassmann R, Fleckenstein B (2011) Cell Surface Markers in HTLV-1 Pathogenesis. Viruses. 3, 1439-1459. *corresponding author. doi: 10.3390/v3081439.
Kress AK*, Schneider G, Pichler K, Kalmer M, Fleckenstein B, Grassmann R (2010) Elevated cyclic AMP (cAMP) levels in T lymphocytes transformed by human T cell lymphotropic virus type 1 (HTLV-1). J Virol. 84:8732-8742. *corresponding author. doi: 10.1128/JVI.00487-10.
Kress AK (2009) Neuigkeiten vom Humanen T-Zell-Leukämie Virus (HTLV): Eindrücke vom HTLV-Weltkongress. Retrovirus Bulletin; 4.
Pichler K, Kattan T, Gentzsch J, Kress AK, Taylor GP, Bangham CRM, Grassmann R (2008) Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients’ T cells by the viral Tax oncoprotein. Blood. 111(9):4741–51. doi: 10.1182/blood-2007-10-115220.
Silbermann K, Pichler K, Kress AK (2008) Humanes T-Zell-Leukämie-Virus (HTLV-1): Pathomechanismen assoziierter Erkrankungen. Retrovirus Bulletin. 3: 7